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Abstract
Objectives: To determine the frequency of metabolic syndrome (MS) in patients with menopau-
se, and to compare the incidence of MS between surgical and natural menopause.
Methods: This was an observational, longitudinal, descriptive, retrospective, unblinded study of 
cases seen at the Menopause Clinic of the University Hospital “Dr. José eleuterio González” 
of the Universidad Autónoma de Nuevo León from March 2009 to December 2011. The frequen- 
cy of MS was determined based on Adult Treatment Panel III (ATPIII) classiication.
Results: at the end of the study, 391 patients were evaluated. The mean age was 50.1 years. We 
found a frequency of MS of 38.1%, the risk factor most often found was low HDL-cholesterol 
(62.5%), followed by obesity (46.5%), hypercholesterolemia (42.3%), hyperglycemia (11.5%), and 
hypertension (7.7%). 
The incidence of natural and surgical menopause was 37.6% vs. 39.2% respectively; however, the 
result was not statistically signiicant (p = 0.093).
Conclusions: Patients with menopause are at increased risk of developing MS. it is important to 
detect MS early in this of patients, when they have one risk factor to avoid complications which 
may trigger the syndrome. We recommend screening for MS during perimenopause, in order to 
detect and try to delay it in a timely manner and recommend primary prevention (diet and 
exercise), or secondary prevention in cases with one or more risk factors. 
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Introduction
Metabolic syndrome is the coexistence of several patholo-
gies or risk factors in a person. This cluster of conditions 
increases the risk of heart disease, stroke, and diabetes me-
llitus. MS has several genetically determined phenotypic va-
riances, as well as being conditioned by environmental 
factors, cardiovascular disease risk factors and abdomi- 
nal fat accumulation.1,2
Menopause refers to the last menstruation cycle as a con-
sequence of the loss of activity in the ovaries. It is identiied 
after 12 months of amenorrhea and it only occurs in hu-
mans. The follicle-stimulating hormone, which stimulates 
growth and storage of the ovarian follicles in the ovary, con-
irms menopause when found in blood greater or equal to 40 
mU/dl. as a result of the complete cessation of ovarian 
activity,3,4 menopause can also be produced artificially 
following bilateral oophorectomy, after abruptly and com-
pletely suppressing the action of the ovaries, causing a 
sharp estrogen drop and losing the ovarian androgenic capa-
city.5 
Menopause brings both hormonal and metabolic changes 
that condition an increase in body weight, producing peri-
pheral insulin resistance, rise in blood pressure, and disor-
ders of lipid metabolism; these are the main components of 
MS. Women between the ages of 17 and 24 and from 25 to 
44 have a prevalence of MS of 3.8% and 16.6% respectively, 
compared to women between the ages of 45 and 64 with 
menopause, who show a prevalence of 35.8%.6,7
in order to diagnose MS the current consensus is based on 
criteria by the National Cholesterol Education Program, 
which indicates that 3 or more of the following risk factors 
are required in order to make a diagnosis in women: abdo-
minal circumference of 88 cm or body mass index (BMi) of 
30 or higher; triglyceride levels higher than 150 mg/dl; 
blood pressure of 130/85 mmHg; blood sugar levels greater 
than 110 mg/dl, and HDL-cholesterol < 50 mg/dl.8,9
The objective of our study was to determine the frequen-
cy of MS in women with menopause. 
Methods 
We carried out an observational, longitudinal, descriptive, 
retrospective, unblinded study of cases seen at the Meno-
pause Clinic of the University Hospital “Dr. José eleuterio 
González” of the Universidad Autónoma de Nuevo León 
from March 2009 to December 2011. We included patients 
consulting for the irst time, patients who had had amenorr-
hea for over a year, patients having undergone bilateral oo-
phorectomy, and patients who had not received hormone 
replacement therapy for at least 3 months prior to the stu-
dy. We performed lab tests as well as a complete somato-
metry. We excluded patients who did not wish to participate 
and those who did not have the required tests. We elimina-
ted patients who abandoned the study or who did not hand 
in complete lab results. We determined the existence of MS 
based on the presence of 3 or more criteria of the aTPiii 
classiication.8,9
We created a database with collected information and 
analyzed it using SPSS® v. 20.0; we applied descriptive 
statistics to the different variables analyzed with average, 
median, mode, and ranges. in addition, we analyzed 
age, occupation, parity, and surgical or artiicial menopau-
se. During physical examinations, we assessed blood pressu-
re, weight, height, and BMI, as well as lab tests, speciically 
lipid proile and fasting serum glucose results. We perfor-
med a statistical analysis using Pearson’s chi square in order 
to analyze the frequency of MS in patients with natural vs. 
surgical menopause. We used convenience sampling. This 
study was approved by the ethics Committee of “Dr. José 
eleuterio González” University Hospital. 
Results
Data from 391 patients were evaluated. The mean age was 
50.1 years with a minimum of 21 and a maximum of 84. Most 
patients were multiparous (73.5%, n = 28), housewives 
(82.4%, n = 322), and had attended the menopause clinic as 
a result of climacteric symptoms (79.3%, n = 310). 
We found a frequency of MS of 38.1% (n = 149).
Only 10% (n = 43) were healthy and 50.8% (n = 199) displa-
yed 1 or 2 criteria for MS, i.e., 1 in every 2 patients with 
menopause present at the University Hospital has at least 1 
MS factor.
regarding the patients with MS, we found that 92 (23%) 
displayed 3 criteria, 44 (11.27%) 4, and 17 (4.34%) 5 or more 
criteria for the syndrome.
The risk factor most often found was low HDL-cholesterol 
(62.5%, n = 245), followed by obesity (182 [46.5%] and pa-
tients who had a BMi greater than 30 kg/m2]. The third most 
frequent factor found was hypercholesterolemia (42.3%, n = 
166), followed by hypertriglyceridemia (38.3%, n = 144). 
The least frequent factors were hyperglycemia and high 
blood pressure (11.5% [n = 45] and 7.7% [n = 30], respecti-
vely) (Table 1).
regarding the comparison of the incidence of MS bet-
ween women with natural and surgical menopause, we 
found a frequency of 37.6% (n = 49) vs. 39.2% (n = 100), 
respectively; this result was not statistically signiicant (p 
= 0.093). 
Metabolic syndrome was more frequent in patients in the 
ifth decade of their lives; comparing the onset of natural 
versus surgical menopause we observed in the latter group 
an onset at a younger age (mean age of 49.2), beginning 
even in the third decade of their lives (21 years).
Table 1 Metabolic syndrome risk factors and frequency. 
risk factor Patients (n) Percentage
Hypertension 30 7.70%
Hyperglycemia 45 11.50%
Hypertriglyceridemia 144 36.80%
Hypercholesterolemia 166 42.30%
Obesity 182 46.50%
Low HDL-cholesterol 245 62.50%
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Discussion
in recent years, MS has become more and more common 
throughout the world, occuring in 25% of the population, 
especially in the US and Latin america where up to one third 
of the population suffers from obesity.10 
We found the syndrome in over a third of our patients 
(38.1%), which concurs with the literature, where an inci-
dence of 30% to 70% is reported.10,11 results from studies 
carried out in Latin america are similar to ours. in 2011, 
Tabares et al. analyzed the cases of MS in 189 postmenopau-
sal women, inding an incidence of 31%.12 in Brazil, albu-
querque evaluated the presence of MS in pre- and 
postmenopausal women, finding a similar percentage to 
ours (34.7%),13 being greater in menopausal women than 
those premenopausal, which concurs with the hypothesis 
in this study.
When comparing in our study the frequency of MS in natu-
ral and surgical menopause, no signiicant differences were 
found; however, the percentage was lower in the irst group. 
In 2008, Dorum A et al. carried out a study in Norway inding 
a higher prevalence of MS in patients who had undergone 
bilateral oophorectomy before 50, hence a greater risk of 
heart diseases.14 
Conclusion
MS is frequent among postmenopausal women attending the 
Menopause Clinic of the “Dr. José eleuterio González” Uni-
versity Hospital. The most frequent criteria for this diagno-
sis were -in order of importance-: low concentrations of 
HDL-cholesterol, obesity, and hypercholesterolemia. Only a 
few patients with menopause did not show any risk factor; 
on the contrary, 50% showed 1 or 2 factors for this syndro-
me. it can be infered that these women are prone to suffer 
some chronic disease; therefore, early detection and action 
to reverse this condition are essential. We did not ind a di-
fference between MS frequencies in patients with natural 
vs. surgical menopause; however, analysis of age groups 
showed that patients who had undergone bilateral oopho-
rectomy were younger than those with natural menopause. 
We recommend screening for MS during perimenopause, to 
detect and try to delay it in a timely manner, having as an 
advantage the fact that this prevention is low-cost and easy 
to perform. 
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